See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Baseball
Natural Disasters
Trade War
Donald Trump
Social Media
Floods
Housing
Taxes
Tennis
Artificial Intelligence
Trade
Published • loading... • Updated

Trial Results Show Autologous Cell Therapy Improves Survival, QOL and Reduces Cardiac Events in Distressed Heart Failure Patients

Summary by DAIC
Increased survival and reduced major adverse cardiac and cerebrovascular events observed study-wide, despite primary composite efficacy endpoint not reaching statistical significance. Patient improvements through two years suggest single dose of CardiAMP therapy offers durable benefits.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
DAICDAIC

Trial Results Show Autologous Cell Therapy Improves Survival, QOL and Reduces Cardiac Events in Distressed Heart Failure Patients

Increased survival and reduced major adverse cardiac and cerebrovascular events observed study-wide, despite primary composite efficacy endpoint not reaching statistical significance. Patient improvements through two years suggest single dose of CardiAMP therapy offers durable benefits.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

DAIC broke the news in on Tuesday, April 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Maryland

Maryland

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal